0.04% +0.010

Deciphera Pharmaceuticals Inc (DCPH)

Deciphera Pharmaceuticals Inc (DCPH) 最新ニュース

Deciphera Pharmaceuticals Inc (DCPH)

Deciphera Pharmaceuticals Inc (DCPH) 最新ニュース

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc ... - GlobeNewswire

(DCPH) On The My Stocks Page - Stock Traders Daily

Russell Investments Group Ltd. Acquires 7326 Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) - Defense World

Panagora Asset Management Inc. Has $3.80 Million Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) - MarketBeat

Can Deciphera Pharmaceuticals, Inc. (DCPH) Climb 79% to Reach the Level Wall Street Analysts Expect? - Yahoo Movies Canada

Deciphera to be acquired by Japan's Ono in all-cash deal valued at $2.4 billion - MSN

New York State Common Retirement Fund Has $383000 Stock Position in Deciphera Pharmaceuticals, Inc. (NASDAQ ... - Defense World

Can Deciphera Pharmaceuticals, Inc. (DCPH) Climb 79% to Reach the Level Wall Street Analysts Expect? - Yahoo Movies Canada

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sees Unusually-High Trading Volume - MarketBeat

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Squarespace, Inc ... - Morningstar

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Squarespace, Inc ... - GlobeNewswire

Is the Options Market Predicting a Spike in Deciphera (DCPH) Stock? - Yahoo Lifestyle UK

DCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024 - MSN

Deciphera Pharmaceuticals, Inc. (DCPH) Down 15% Since Last Earnings Report: Can It Rebound? - Yahoo Canada Shine On

Deciphera Pharmaceuticals (NASDAQ:DCPH) Reaches New 12-Month High at $25.55 - Defense World

Deciphera Pharmaceuticals (DCPH) Stock Forecast and Price Target 2024 - MarketBeat

Fisher Asset Management LLC Takes $1.01 Million Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) - MarketBeat

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 1-Year High at $25.55 - MarketBeat

Analysts Estimate Deciphera Pharmaceuticals, Inc. (DCPH) to Report a Decline in Earnings: What to Look Out for - Yahoo News UK

Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings - Yahoo Finance

Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Canada Finance

Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates - Zacks Investment Research

How the (DCPH) price action is used to our Advantage - Stock Traders Daily

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 1-Year High at $25.55 - MarketBeat

AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PlayAGS ... - GlobeNewswire

Analysts Estimate Deciphera Pharmaceuticals, Inc. (DCPH) to Report a Decline in Earnings: What to Look Out for - Yahoo News UK

Deciphera Pharmaceuticals (DCPH) – Investment Analysts' Weekly Ratings Changes - Defense World

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PlayAGS ... - GlobeNewswire

Deciphera Pharmaceuticals (NASDAQ:DCPH) shareholders have endured a 66% loss from investing in the stock three ... - Yahoo Lifestyle UK

Deciphera Pharmaceuticals, Inc. to Post Q1 2025 Earnings of ($0.57) Per Share, Zacks Research Forecasts (NASDAQ ... - MarketBeat

Zacks Research Analysts Cut Earnings Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) - Defense World

Wall Street Breakfast: The Week Ahead

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, DPSI, UNIT - ForexTV.com

The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine

Deciphera Pharmaceuticals (NASDAQ:DCPH) Downgraded by Leerink Partnrs to Market Perform - Defense World

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Sees Significant Decline in Short Interest - Defense World

Deciphera Pharmaceuticals (NASDAQ:DCPH) Stock Rating Reaffirmed by JMP Securities - Defense World

Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More

Barclays Upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) to “Equal Weight” - Defense World

Deciphera acquisition by ONO Pharmaceutical at $2.4 billion - Investing.com India

DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates ... - Business Wire

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Short Interest Down 5.1% in April - MarketBeat

Deciphera acquisition by ONO Pharmaceutical at $2.4 billion By Investing.com - Investing.com

Deciphera Pharmaceuticals' (DCPH) Neutral Rating Reiterated at Guggenheim - MarketBeat

Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)

ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals - PR Newswire

Deciphera Pharmaceuticals' (DCPH) Neutral Rating Reiterated at Guggenheim - MarketBeat

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HashiCorp Inc ... - GlobeNewswire

Acquisition Deal Propel Deciphera (DCPH) Shares - Stocks Telegraph

DCPHに似た銘柄